The present work aimed to explore the mechanism by which BYF restores the Th17/Treg balance in vitro and in vivo and evaluate the critical role of A2aR in the subsequent anti-COPD effect of BYF. Here, ADORA2A is linked to chronic obstructive pulmonary disease.